Publications

5600 Results

4q Copy Neutral Loss of Heterozygosity and KMT2A Partial Tandem Duplication Identified By Chromosomal Genomic Array Testing (CGAT) Correlated with Decreased Overall Survival in Acute Myeloid Leukemia (AML)

Authors
S Raychaudhuri;T Gooley;M Othus;X Qu;C Shaw;K Russell;R Vyas;J Appelbaum;A Halpern;R Walter;H Erba;M Fang;M Percival
Journal / Conference
ASH Annual Meeting (December 7-10, 2024, in San Diego, CA), poster
Year
2024
Research Committee(s)
Leukemia

Lack of benefit of autologous hematopoietic cell transplantation (auto-HCT) in mantle cell lymphoma (MCL) patients (pts) in minimal residual disease (MRD)-negative first complete remission (CR): Initial report from ECOG-ACRIN EA4151

Authors
T Fenske;X Wang;B Till;K Blum;M Lunning;H Lazarus;P Fishkin;L Shields;D Scott;A LaCasce;P Johnson;A Cashen;L Popplewell;R Dean;N Shah;N Wagner-Johnston;B Hu;B Dholaria;R Little;JW Friedberg;J Leonard;B Kahl
Journal / Conference
ASH Annual Meeting (December 7-10, 2024, in San Diego, CA), oral
Year
2024
Research Committee(s)
Lymphoma

Trial in Progress – Alliance A052101: A randomized phase 3 trial of continuous vs. intermittent maintenance therapy with zanubrutinib as upfront treatment in older patients with mantle cell lymphoma

Authors
A Beaven;S Geyer;J Cohen;T Phillips;T Dockter;P Pophali;G Thanarajasingam;G Mazza;A Alencar;S Dinner;E Hsi;M Welliver;D Nikcevich;B Kahl;JW Friedberg;N Bartlett;J Leonard
Journal / Conference
ASH Annual Meeting (December 7-10, 2024, in San Diego, CA), poster
Year
2024
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/A052101

Outcome and Treatment Toxicity at Community versus Academic Sites for Patients with Rare Cancers on Immune Checkpoint Inhibitors (NCI/SWOG S1609)

Authors
J Jawara;L Cavalcante;S Patel;Y Chae;M Othus;R Kurzrock
Journal / Conference
ABRCMS 2024 Graduate Symposium (Nov. 13-16 in Pittsburgh, PA), poster
Year
2024
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers (SWOG S1815; NCT#03768414)

Authors
R Shroff;G King;S Colby;A Scott;M Borad;K Matin;A Mahipal;A Kalyan;M Javle;I El Dika;B Tan;P Cheema;A Patel;R Iyer;R Kelley;J Thumar;A El-Khoueiry;K Guthrie;EG Chiorean;H Hochster;P Philip
Journal / Conference
Journal of Clinical Oncology Dec 13:JCO2401383. doi: 10.1200/JCO-24-01383. Online ahead of print
Year
2024
Research Committee(s)
Gastrointestinal
PMID
PMID39671534
Study Number(s)
S1815

Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive BC in the Phase III RxPONDER Trial (SWOG S1007)

Authors
Y Abdou;W Barlow;J Gralow;F Meric-Bernstam;K Albain;D Hayes;N Lin;E Perez;L Goldstein;S Chia;S Dhesy-Thind;P Rastogi;E Alba;S Delaloge;A Schott;S Shak;P Sharma;D Lew;J Miao;J Unger;D Tripathy;L Pusztai;G Hortobagyi;K Kalinsky
Journal / Conference
JAMA Oncology Dec 5:djae314. doi: 10.1093/jnci/djae314. Online ahead of print
Year
2024
Research Committee(s)
Breast
Study Number(s)
S1007

Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929

Authors
N Abdel Karim;J Miao;K Reckamp;C Gay;L Byers;Y Zhao;M Redman;D Carrizosa;W Wang;W Petty;K Mehta;B Faller;E Agamah;S Kasbari;R Malisetti;A Kumar;J Schallenkamp;K Alluri;J Gray;K Kelly
Journal / Conference
Journal of Thoracic Oncology Nov 4:S1556-0864(24)02431-6
Year
2024
Research Committee(s)
Lung
PMID
PMID39505259
Study Number(s)
S1929

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patient with RAS/BRAF wild-type, HER2-positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase 2 Trial

Authors
K Raghav;K Guthrie;B Tan;C Denlinger;M Fakih;M Overman;NA Dasari;L Corum;L Hicks;M Patel;B Esparaz;S Kazmi;N Alluri;S Colby;S Gholami;P Gold;EG Chiorean;ES Kopetz;H Hochster;PA Philip
Journal / Conference
Journal of Clinical Oncology Sep;25(9):1147-1162
Year
2024
Research Committee(s)
Gastrointestinal
Study Number(s)
S1613

Intracluster Correlation Coefficients from Cluster Randomized Trials Conducted within the NCI Community Oncology Research Program (NCORP)

Authors
A Snavely;H Gunn;J Lee;S Pugh;W Barlow;E Culacova;K Arnold;C Kittel;S Smith;B Hanlon;A Tan;T Dockter;D Zahrieh;E Dressler
Journal / Conference
JNCI Monographs
Year
2024
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1415CD

Improved outcomes with 7+3 induction chemotherapy for acute myeloid leukemia over the past four decades: Analysis of SWOG trial data

Authors
M Othus;G Garcia-Manero;J Godwin;J Weick;F Appelbaum;H Erba;E Estey
Journal / Conference
Haematologica Jan 1;108(1):42-47
Year
2023
Research Committee(s)
Leukemia
PMID
PMID35833298
PMC
PMC9827148
Study Number(s)
S0106, S1203, SWOG-8600, SWOG-9031